“…Current treatment models use PN to assist patients receiving SUD treatment to maintain treatment, recovery, and prevent relapse (Eddie et al, 2019). The success of the PN model has been reproduced within CJ-specific environments, with studies showing that PN improves linkage to primary care (Jordan et al, 2013), HIV care (Myers et al, 2018;Westergaard et al, 2019;Wohl et al, 2016), retention in HIV care (Cunningham et al, 2018), ART uptake and adherence (Teixeria, Jordan, Zaller, Shah, & Venters, 2015), and viral suppression (Wohl et al, 2016) (Teixeria et al, 2015) upon release from the CJ system. For non CJ-involved individuals, PN has been shown to decrease time to PrEP initiation (Spinelli et al, 2018), increase HCV treatment initiation (Ford, Johnson, Desai, Rude, & Laraque, 2016;Trooskin et al, 2015), and improve retention in HCV treatment (Trooskin et al, 2015) and SVR (Ford et al, 2016).…”